 Sheri Johnson
Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bipolar Disorder | 43 | 2025 | 264 | 11.040 |
Why?
| | Impulsive Behavior | 22 | 2025 | 149 | 7.600 |
Why?
| | Emotions | 20 | 2025 | 545 | 3.900 |
Why?
| | Affect | 16 | 2025 | 292 | 1.650 |
Why?
| | Reward | 10 | 2021 | 244 | 1.600 |
Why?
| | Personality | 6 | 2018 | 132 | 1.580 |
Why?
| | Motivation | 8 | 2019 | 567 | 1.380 |
Why?
| | Creativity | 3 | 2015 | 16 | 1.280 |
Why?
| | Suicidal Ideation | 3 | 2023 | 522 | 1.020 |
Why?
| | Achievement | 4 | 2015 | 57 | 1.010 |
Why?
| | Depressive Disorder, Major | 5 | 2020 | 362 | 1.000 |
Why?
| | Cognitive Dysfunction | 2 | 2023 | 381 | 0.940 |
Why?
| | Self Report | 10 | 2022 | 822 | 0.940 |
Why?
| | Social Behavior | 3 | 2018 | 284 | 0.940 |
Why?
| | Psychopathology | 3 | 2023 | 56 | 0.930 |
Why?
| | Rumination, Cognitive | 1 | 2025 | 10 | 0.930 |
Why?
| | Quality of Life | 5 | 2024 | 2878 | 0.910 |
Why?
| | Mood Disorders | 2 | 2016 | 129 | 0.910 |
Why?
| | Borderline Personality Disorder | 2 | 2015 | 15 | 0.870 |
Why?
| | Diet, Mediterranean | 1 | 2024 | 30 | 0.860 |
Why?
| | Interpersonal Relations | 3 | 2018 | 396 | 0.830 |
Why?
| | Social Dominance | 2 | 2021 | 21 | 0.820 |
Why?
| | Affective Symptoms | 2 | 2015 | 53 | 0.790 |
Why?
| | Prefrontal Cortex | 3 | 2024 | 304 | 0.730 |
Why?
| | Young Adult | 25 | 2025 | 13127 | 0.690 |
Why?
| | Male | 51 | 2025 | 67311 | 0.670 |
Why?
| | Cognitive Remediation | 1 | 2020 | 3 | 0.670 |
Why?
| | Anticipation, Psychological | 1 | 2019 | 18 | 0.640 |
Why?
| | Imagination | 1 | 2019 | 18 | 0.640 |
Why?
| | Adult | 39 | 2025 | 37631 | 0.640 |
Why?
| | Female | 49 | 2025 | 72795 | 0.630 |
Why?
| | Humans | 75 | 2025 | 136765 | 0.630 |
Why?
| | Life Change Events | 3 | 2015 | 151 | 0.620 |
Why?
| | Prejudice | 1 | 2019 | 72 | 0.610 |
Why?
| | Goals | 4 | 2015 | 169 | 0.600 |
Why?
| | Psychiatric Status Rating Scales | 11 | 2021 | 547 | 0.580 |
Why?
| | Cyclothymic Disorder | 2 | 2015 | 5 | 0.580 |
Why?
| | Social Environment | 3 | 2018 | 295 | 0.580 |
Why?
| | Aggression | 3 | 2015 | 200 | 0.570 |
Why?
| | Tryptophan | 1 | 2019 | 183 | 0.570 |
Why?
| | Nucleus Accumbens | 1 | 2019 | 138 | 0.570 |
Why?
| | Brain Mapping | 3 | 2019 | 504 | 0.570 |
Why?
| | Depression | 8 | 2021 | 1396 | 0.570 |
Why?
| | Mental Disorders | 3 | 2023 | 1070 | 0.570 |
Why?
| | Cognition | 2 | 2023 | 1146 | 0.540 |
Why?
| | Attention | 3 | 2012 | 426 | 0.530 |
Why?
| | Thinking | 3 | 2018 | 65 | 0.520 |
Why?
| | Psychotic Disorders | 2 | 2017 | 169 | 0.520 |
Why?
| | Mental Recall | 2 | 2009 | 201 | 0.470 |
Why?
| | Anger | 1 | 2015 | 60 | 0.470 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 4 | 2022 | 75 | 0.470 |
Why?
| | Entrepreneurship | 1 | 2014 | 6 | 0.460 |
Why?
| | Adolescent | 24 | 2021 | 21382 | 0.460 |
Why?
| | Suicide, Attempted | 2 | 2023 | 373 | 0.450 |
Why?
| | Income | 1 | 2015 | 202 | 0.440 |
Why?
| | Mindfulness | 4 | 2021 | 117 | 0.430 |
Why?
| | Arousal | 3 | 2023 | 155 | 0.420 |
Why?
| | Intention | 1 | 2014 | 169 | 0.400 |
Why?
| | Inpatients | 1 | 2017 | 496 | 0.390 |
Why?
| | Health Status Disparities | 1 | 2015 | 283 | 0.380 |
Why?
| | Global Health | 1 | 2015 | 385 | 0.380 |
Why?
| | Randomized Controlled Trials as Topic | 5 | 2025 | 1462 | 0.380 |
Why?
| | Circadian Rhythm | 3 | 2024 | 469 | 0.380 |
Why?
| | Adolescent Behavior | 1 | 2017 | 529 | 0.360 |
Why?
| | Behavior | 1 | 2011 | 90 | 0.360 |
Why?
| | Mental Health Services | 1 | 2016 | 416 | 0.350 |
Why?
| | Sleep Wake Disorders | 2 | 2024 | 283 | 0.350 |
Why?
| | Risk Factors | 11 | 2023 | 10325 | 0.340 |
Why?
| | Decision Making | 1 | 2018 | 898 | 0.340 |
Why?
| | Healthcare Disparities | 1 | 2016 | 649 | 0.310 |
Why?
| | Depressive Disorder | 3 | 2014 | 379 | 0.310 |
Why?
| | Memory, Short-Term | 4 | 2025 | 249 | 0.310 |
Why?
| | Memory, Episodic | 1 | 2009 | 51 | 0.300 |
Why?
| | Wounds and Injuries | 1 | 2015 | 755 | 0.300 |
Why?
| | Brain-Derived Neurotrophic Factor | 3 | 2015 | 131 | 0.300 |
Why?
| | Cross-Sectional Studies | 7 | 2022 | 5423 | 0.290 |
Why?
| | Anxiety | 4 | 2021 | 1031 | 0.270 |
Why?
| | Surveys and Questionnaires | 8 | 2021 | 5742 | 0.270 |
Why?
| | Pilot Projects | 2 | 2025 | 1692 | 0.270 |
Why?
| | Convalescence | 1 | 2007 | 17 | 0.270 |
Why?
| | Middle Aged | 18 | 2025 | 33228 | 0.250 |
Why?
| | Social Support | 3 | 2018 | 616 | 0.250 |
Why?
| | Nerve Net | 2 | 2019 | 256 | 0.230 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 5 | 2025 | 243 | 0.230 |
Why?
| | Models, Psychological | 2 | 2017 | 302 | 0.220 |
Why?
| | Students | 5 | 2023 | 624 | 0.220 |
Why?
| | Mental Processes | 1 | 2004 | 32 | 0.220 |
Why?
| | Phobic Disorders | 1 | 2004 | 33 | 0.220 |
Why?
| | Galvanic Skin Response | 2 | 2016 | 24 | 0.220 |
Why?
| | Risk | 3 | 2015 | 908 | 0.210 |
Why?
| | Personality Assessment | 2 | 2014 | 84 | 0.210 |
Why?
| | Cooperative Behavior | 1 | 2006 | 445 | 0.210 |
Why?
| | Yohimbine | 1 | 2023 | 10 | 0.210 |
Why?
| | Fasting | 1 | 2024 | 280 | 0.200 |
Why?
| | Waiting Lists | 1 | 2025 | 262 | 0.200 |
Why?
| | Personality Inventory | 3 | 2014 | 140 | 0.200 |
Why?
| | Endophenotypes | 1 | 2022 | 21 | 0.200 |
Why?
| | Psychology | 2 | 2020 | 85 | 0.200 |
Why?
| | Antidepressive Agents | 2 | 2020 | 235 | 0.190 |
Why?
| | Clinical Trials as Topic | 2 | 2024 | 1044 | 0.190 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2015 | 2184 | 0.190 |
Why?
| | Magnetic Resonance Imaging | 3 | 2024 | 3555 | 0.180 |
Why?
| | Brain | 3 | 2025 | 2664 | 0.180 |
Why?
| | Patient Care Team | 1 | 2006 | 626 | 0.180 |
Why?
| | Heart Rate | 3 | 2016 | 820 | 0.180 |
Why?
| | Social Sciences | 1 | 2020 | 8 | 0.170 |
Why?
| | Psychotherapy | 2 | 2017 | 167 | 0.170 |
Why?
| | Self-Assessment | 2 | 2019 | 72 | 0.170 |
Why?
| | 5-Hydroxytryptophan | 1 | 2020 | 21 | 0.160 |
Why?
| | Vitamin B 6 | 1 | 2019 | 10 | 0.160 |
Why?
| | Sexism | 1 | 2020 | 61 | 0.160 |
Why?
| | Anxiety Disorders | 3 | 2017 | 374 | 0.160 |
Why?
| | Comorbidity | 4 | 2017 | 1614 | 0.160 |
Why?
| | Perfectionism | 1 | 2019 | 3 | 0.160 |
Why?
| | Psychotherapy, Group | 1 | 2019 | 66 | 0.150 |
Why?
| | Stress, Psychological | 2 | 2018 | 1097 | 0.150 |
Why?
| | Genetic Predisposition to Disease | 4 | 2014 | 2412 | 0.150 |
Why?
| | Executive Function | 2 | 2025 | 440 | 0.150 |
Why?
| | Racism | 1 | 2021 | 135 | 0.150 |
Why?
| | Personality Tests | 1 | 2018 | 16 | 0.140 |
Why?
| | Pessimism | 1 | 2018 | 9 | 0.140 |
Why?
| | Therapy, Computer-Assisted | 1 | 2018 | 62 | 0.140 |
Why?
| | Child Abuse | 2 | 2015 | 528 | 0.140 |
Why?
| | Psychology, Social | 1 | 2017 | 12 | 0.140 |
Why?
| | Judgment | 1 | 2018 | 60 | 0.140 |
Why?
| | Neuropsychological Tests | 2 | 2025 | 1022 | 0.140 |
Why?
| | Brain Waves | 1 | 2017 | 34 | 0.130 |
Why?
| | Trust | 1 | 2018 | 120 | 0.130 |
Why?
| | Leadership | 1 | 2021 | 382 | 0.130 |
Why?
| | Eating | 1 | 2019 | 379 | 0.130 |
Why?
| | Respiratory Sinus Arrhythmia | 1 | 2016 | 15 | 0.130 |
Why?
| | Empathy | 1 | 2019 | 169 | 0.130 |
Why?
| | Neuroimaging | 1 | 2019 | 259 | 0.130 |
Why?
| | Military Personnel | 1 | 2023 | 544 | 0.130 |
Why?
| | Schizophrenic Psychology | 1 | 2017 | 94 | 0.130 |
Why?
| | Alcohol Drinking | 1 | 2023 | 820 | 0.130 |
Why?
| | Recurrence | 1 | 2020 | 1055 | 0.130 |
Why?
| | Science | 1 | 2017 | 53 | 0.130 |
Why?
| | Schizophrenia | 1 | 2021 | 438 | 0.130 |
Why?
| | Risk Assessment | 2 | 2018 | 3432 | 0.130 |
Why?
| | Self-Management | 1 | 2018 | 166 | 0.120 |
Why?
| | Choice Behavior | 1 | 2017 | 170 | 0.120 |
Why?
| | Receptors, Opioid, mu | 1 | 2015 | 74 | 0.120 |
Why?
| | Antipsychotic Agents | 2 | 2008 | 193 | 0.120 |
Why?
| | Remission Induction | 1 | 2015 | 288 | 0.110 |
Why?
| | Adult Survivors of Child Adverse Events | 1 | 2014 | 12 | 0.110 |
Why?
| | Receptors, Dopamine D4 | 1 | 2014 | 26 | 0.110 |
Why?
| | Catechol O-Methyltransferase | 1 | 2014 | 17 | 0.110 |
Why?
| | Case-Control Studies | 5 | 2018 | 3539 | 0.110 |
Why?
| | Genotype | 2 | 2022 | 1914 | 0.110 |
Why?
| | Tryptophan Hydroxylase | 1 | 2014 | 53 | 0.110 |
Why?
| | Gene-Environment Interaction | 1 | 2015 | 190 | 0.110 |
Why?
| | Regression Analysis | 2 | 2014 | 1022 | 0.110 |
Why?
| | Research | 1 | 2017 | 448 | 0.110 |
Why?
| | Self Concept | 2 | 2014 | 249 | 0.110 |
Why?
| | Receptors, Dopamine D2 | 1 | 2014 | 97 | 0.110 |
Why?
| | Predictive Value of Tests | 3 | 2011 | 2022 | 0.100 |
Why?
| | Respiration | 2 | 2011 | 199 | 0.100 |
Why?
| | Socioeconomic Factors | 1 | 2018 | 1282 | 0.100 |
Why?
| | Learning | 1 | 2017 | 406 | 0.100 |
Why?
| | Suicide | 2 | 2013 | 645 | 0.100 |
Why?
| | Frustration | 1 | 2012 | 8 | 0.100 |
Why?
| | Prevalence | 2 | 2017 | 2710 | 0.090 |
Why?
| | Personality Disorders | 2 | 2017 | 75 | 0.090 |
Why?
| | Sleep | 1 | 2018 | 753 | 0.090 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2014 | 428 | 0.090 |
Why?
| | Happiness | 1 | 2011 | 21 | 0.090 |
Why?
| | Parasympathetic Nervous System | 1 | 2011 | 27 | 0.090 |
Why?
| | Epistasis, Genetic | 1 | 2011 | 70 | 0.090 |
Why?
| | Memory | 2 | 2011 | 248 | 0.080 |
Why?
| | Disruptive, Impulse Control, and Conduct Disorders | 1 | 2008 | 11 | 0.080 |
Why?
| | Autonomic Nervous System | 1 | 2009 | 75 | 0.080 |
Why?
| | Social Control, Informal | 1 | 2008 | 21 | 0.080 |
Why?
| | Prospective Studies | 3 | 2011 | 7572 | 0.070 |
Why?
| | Neurotransmitter Agents | 2 | 2006 | 82 | 0.070 |
Why?
| | Membrane Proteins | 1 | 2014 | 1163 | 0.070 |
Why?
| | Polymorphism, Genetic | 1 | 2011 | 659 | 0.070 |
Why?
| | Family Therapy | 1 | 2008 | 65 | 0.070 |
Why?
| | Vocabulary | 1 | 2007 | 38 | 0.070 |
Why?
| | United States | 3 | 2023 | 14690 | 0.060 |
Why?
| | Serotonin | 1 | 2008 | 323 | 0.060 |
Why?
| | Lithium Compounds | 1 | 2006 | 12 | 0.060 |
Why?
| | Antimanic Agents | 1 | 2006 | 17 | 0.060 |
Why?
| | Follow-Up Studies | 3 | 2015 | 5106 | 0.060 |
Why?
| | Functional Neuroimaging | 1 | 2025 | 55 | 0.060 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2025 | 56 | 0.060 |
Why?
| | Discrimination Learning | 1 | 2004 | 46 | 0.060 |
Why?
| | Single-Blind Method | 1 | 2025 | 282 | 0.060 |
Why?
| | Substance-Related Disorders | 1 | 2013 | 1069 | 0.050 |
Why?
| | Verbal Learning | 1 | 2004 | 60 | 0.050 |
Why?
| | Facial Expression | 1 | 2004 | 72 | 0.050 |
Why?
| | Anticonvulsants | 1 | 2006 | 215 | 0.050 |
Why?
| | Pattern Recognition, Visual | 1 | 2004 | 101 | 0.050 |
Why?
| | Cost of Illness | 1 | 2006 | 302 | 0.050 |
Why?
| | Reading | 1 | 2004 | 135 | 0.050 |
Why?
| | Attitude to Health | 1 | 2006 | 437 | 0.050 |
Why?
| | Monoamine Oxidase | 1 | 2022 | 30 | 0.050 |
Why?
| | Patient Compliance | 1 | 2006 | 577 | 0.050 |
Why?
| | Physician-Patient Relations | 1 | 2006 | 548 | 0.050 |
Why?
| | Professional Practice | 1 | 2021 | 64 | 0.040 |
Why?
| | Psychological Theory | 1 | 2020 | 97 | 0.040 |
Why?
| | Patient Education as Topic | 2 | 2019 | 761 | 0.040 |
Why?
| | Bias | 1 | 2021 | 218 | 0.040 |
Why?
| | Proof of Concept Study | 1 | 2019 | 78 | 0.040 |
Why?
| | Longitudinal Studies | 1 | 2006 | 2829 | 0.040 |
Why?
| | Pupil | 1 | 2018 | 15 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2006 | 2822 | 0.040 |
Why?
| | Netherlands | 1 | 2018 | 88 | 0.040 |
Why?
| | Psychology, Experimental | 1 | 2017 | 1 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2017 | 10745 | 0.030 |
Why?
| | Australia | 1 | 2018 | 313 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2017 | 307 | 0.030 |
Why?
| | Sociological Factors | 1 | 2015 | 5 | 0.030 |
Why?
| | Reference Values | 1 | 2017 | 816 | 0.030 |
Why?
| | Child | 1 | 2015 | 21819 | 0.030 |
Why?
| | Genotyping Techniques | 1 | 2015 | 75 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2018 | 587 | 0.030 |
Why?
| | Heterozygote | 1 | 2015 | 293 | 0.030 |
Why?
| | Psychometrics | 1 | 2018 | 720 | 0.030 |
Why?
| | Internet | 1 | 2018 | 647 | 0.030 |
Why?
| | Linear Models | 1 | 2015 | 846 | 0.030 |
Why?
| | Interview, Psychological | 1 | 2013 | 96 | 0.020 |
Why?
| | Universities | 1 | 2015 | 433 | 0.020 |
Why?
| | Communication | 1 | 2017 | 875 | 0.020 |
Why?
| | Alcoholism | 1 | 2017 | 804 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3265 | 0.020 |
Why?
| | Cohort Studies | 1 | 2020 | 5701 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2011 | 375 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 1316 | 0.020 |
Why?
| | Electrocardiography | 1 | 2011 | 629 | 0.020 |
Why?
| | Vagus Nerve | 1 | 2008 | 86 | 0.020 |
Why?
| | Antisocial Personality Disorder | 1 | 2008 | 168 | 0.020 |
Why?
| | Aged | 2 | 2021 | 23794 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 6808 | 0.020 |
Why?
| | Conduct Disorder | 1 | 2008 | 201 | 0.020 |
Why?
| | Cues | 1 | 2008 | 313 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2008 | 1231 | 0.010 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2008 | 413 | 0.010 |
Why?
| | Terminology as Topic | 1 | 2005 | 216 | 0.010 |
Why?
| | Adaptation, Psychological | 1 | 2008 | 651 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 2005 | 1481 | 0.010 |
Why?
| | Research Design | 1 | 2005 | 1127 | 0.010 |
Why?
| | Animals | 1 | 2019 | 36847 | 0.010 |
Why?
|
|
Johnson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|